NFKB1 and hepatitis C virus infection: Given the promise of microRNA-based therapeutics in Hepatitis C (Janssen et al., 2013), it will be exciting to watch for developments of therapies that harness the ability of microRNAs to regulate NF-κB signaling in vascular diseases.